We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an e... Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 2.25 | 23.0532786885 | 9.76 | 12.3399 | 8.43 | 69802 | 10.28387635 | CS |
52 | 8.06 | 204.050632911 | 3.95 | 24 | 2.66 | 3018577 | 11.16807576 | CS |
156 | -168.49 | -93.3462603878 | 180.5 | 212.5 | 2.66 | 1298659 | 22.47090019 | CS |
260 | -158.24 | -92.9456681351 | 170.25 | 284.5 | 2.66 | 793532 | 38.10406375 | CS |
Symbol | Price | Vol. |
---|---|---|
GWAVGreenwave Technology Solutions Inc | $ 0.0692 (19.10%) | 154.93M |
SGDSafe and Green Development Corporation | $ 0.7725 (24.60%) | 94.1M |
SQQQProShares UltraPro Short QQQ | $ 10.70 (-0.37%) | 75.18M |
CPOPPop Culture Group Company Ltd | $ 2.9201 (71.77%) | 72.67M |
FFIEFaraday Future Intelligent Electric Inc | $ 0.0403 (-3.59%) | 67.88M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions